(Q34067406)

30 July 2017

1 reference

title

Treatment and outcomes for elderly patients with small cell lung cancer (English)

1 reference

30 July 2017

1 reference

Stephens RJ

1

1 reference

30 July 2017

Johnson DH

series ordinal

2

1 reference

30 July 2017

publication date

1 September 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

17

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

229-247

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200017030-00006

30 July 2017

exact match

0 references

cites work

The influence of age on the delivery, tolerance, and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer

1 reference

12 December 2020

A prospective randomised study in limited disease small cell carcinoma--doxorubicin and vincristine plus either cyclophosphamide or etoposide

1 reference

12 December 2020

Renal tolerance of cisplatin in patients more than 80 years old

1 reference

12 December 2020

1 reference

12 December 2020

The clinical effect of medroxyprogesterone (MPA) in elderly patients with lung cancer.

1 reference

12 December 2020

Prognostic factors of small-cell lung cancer in Okayama Lung Cancer Study Group Trials

1 reference

12 December 2020

Small-cell carcinoma of the lung: derivation of a prognostic staging system.

1 reference

12 December 2020

Unexpected high toxicity in a phase II study of teniposide (VM-26) in elderly patients with untreated small cell lung cancer (SCLC)

1 reference

12 December 2020

Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung

1 reference

12 December 2020

Clinical trials and drug toxicity in the elderly. The experience of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

Cyclophosphamide, doxorubicin, and etoposide as first-line therapy in the treatment of small-cell lung cancer

1 reference

12 December 2020

Full chemotherapy in elderly patients with small cell bronchial carcinoma

1 reference

12 December 2020

Carboplatin/etoposide in small cell lung cancer

1 reference

12 December 2020

Prognostic factors and prognostic staging system for small cell lung cancer

1 reference

12 December 2020

Choice of cancer therapy varies with age of patient

1 reference

12 December 2020

Lack of age-dependent cisplatin nephrotoxicity

1 reference

12 December 2020

Representation of older patients in cancer treatment trials

1 reference

12 December 2020

Clinical evidence for a change in tumor aggressiveness with age.

1 reference

12 December 2020

VP-16-213 in combination chemotherapy with chest irradiation for small-cell lung cancer: a randomized trial of the Piedmont Oncology Association

1 reference

12 December 2020

Teniposide as single drug therapy for elderly patients affected by small cell lung cancer

1 reference

12 December 2020

Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III study. Hellenic Cooperative Oncology Group for Lung Cancer Trials.

1 reference

12 December 2020

The psychosocial impact of cancer on the elderly: a comparison with younger patients

1 reference

12 December 2020

Importance of dose and dose intensity in the treatment of small-cell lung cancer

1 reference

12 December 2020

Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study

1 reference

12 December 2020

Management of lung cancer

1 reference

12 December 2020

Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base

1 reference

12 December 2020

Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.

1 reference

12 December 2020

Age trends of lung cancer stage at diagnosis. Implications for lung cancer screening in the elderly

1 reference

12 December 2020

Addition of etoposide to cyclophosphamide, doxorubicin, and vincristine for remission induction and survival in patients with small cell lung cancer.

1 reference

12 December 2020

Teniposide (VM26) as second-line treatment for small cell lung cancer

1 reference

12 December 2020

Carboplatin (JM8) as a single agent and in combination in the treatment of small cell lung cancer

1 reference

12 December 2020

VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules

1 reference

12 December 2020

Influence of age on the treatment of limited-stage small-cell lung cancer

1 reference

12 December 2020

Trading treatment toxicity for survival in locally advanced non-small cell lung cancer.

1 reference

12 December 2020

New combination of the old drugs for elderly patients with small-cell lung cancer: a phase II study of the PAVE regimen

1 reference

12 December 2020

Intensive weekly chemotherapy for the treatment of extensive-stage small-cell lung cancer

1 reference

12 December 2020

Carboplatin and etoposide in extensive small cell lung cancer

1 reference

12 December 2020

A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer

1 reference

12 December 2020

Age and the treatment of lung cancer

1 reference

12 December 2020

Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer

1 reference

12 December 2020

Psychosocial consequences of cancer chemotherapy for elderly patients

1 reference

12 December 2020

Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer

1 reference

12 December 2020

Hoosier Oncology Group studies in extensive and recurrent small cell lung cancer

1 reference

12 December 2020

Cancer and old age.An autopsy study of 3,535 patients over 65 years old

1 reference

12 December 2020

Etoposide in the treatment of elderly/poor-prognosis patients with small-cell lung cancer

1 reference

12 December 2020

Small Cell Lung Carcinoma in the Elderly

1 reference

12 December 2020

Second-line chemotherapy for relapsed small cell lung cancer

1 reference

12 December 2020

Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.

1 reference

12 December 2020

Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: a randomized trial

1 reference

12 December 2020

Treatment of small cell lung cancer in the elderly: the progress and limitation of chemotherapy

1 reference

12 December 2020

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group

1 reference

12 December 2020

Analysis of thrombocytopenia due to carboplatin combined with etoposide in elderly patients with lung cancer

1 reference

12 December 2020

Reducing chemotherapy-associated toxicity in elderly cancer patients

1 reference

12 December 2020

CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer

1 reference

12 December 2020

Treatment of small cell lung cancer in the elderly

1 reference

12 December 2020

Neurotoxicity secondary to antineoplastic drugs

1 reference

12 December 2020

Decision analysis of hematopoietic growth factor use in patients receiving cancer chemotherapy

1 reference

12 December 2020

Small cell carcinoma of the lung: influence of age on treatment outcome

1 reference

12 December 2020

Recombinant hemopoietic growth factors: comparative hemopoietic response in younger and older subjects

1 reference

12 December 2020

A meta-analysis of thoracic radiotherapy for small-cell lung cancer

1 reference

12 December 2020

Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients.

1 reference

12 December 2020

Treatment of small cell anaplastic carcinoma of the lung with the oral solution of VP-16-213 (NSC 141540, 4′-demethylepipodophyllotoxin 9-(4,6-0-ethylidene-β-D-glucopyranoside)

1 reference

12 December 2020

Small-cell lung cancer in elderly patients: the case for chemotherapy

1 reference

12 December 2020

Teniposide and etoposide in previously untreated small-cell lung cancer: a randomized study

1 reference

12 December 2020

Long-term follow-up of a randomised trial of combined chemoradiotherapy induction treatment, with and without maintenance chemotherapy in patients with small cell carcinoma of the lung

1 reference

12 December 2020

Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public

1 reference

12 December 2020

Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada

1 reference

12 December 2020

Underrepresentation of patients 65 years of age or older in cancer-treatment trials

1 reference

12 December 2020

Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients

1 reference

12 December 2020

Weekly carboplatin and VM-26 for elderly patients with small-cell lung cancer

1 reference

12 December 2020

Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Medical Research Council Lung Cancer Working Party.

1 reference

12 December 2020

Does knowledge guide practice? Another look at the management of non-small-cell lung cancer

1 reference

12 December 2020

The influence of patient age on the diagnosis and treatment of lung and colorectal cancer

1 reference

12 December 2020

Oral etoposide and carboplatin. Effective therapy for elderly patients with small cell lung cancer

1 reference

12 December 2020

Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation

1 reference

12 December 2020

Paclitaxel, carboplatin, and extended-schedule oral etoposide for small-cell lung cancer

1 reference

12 December 2020

Effective new low toxicity chemotherapy with carboplatin, vinblastine and methotrexate for small cell lung cancer: a randomised trial against doxorubicin, cyclophosphamide and etoposide

1 reference

12 December 2020

Aggressive Chemotherapy for Diffuse Histiocytic Lymphoma in the Elderly: Increased Complications with Advancing Age

1 reference

12 December 2020

Amifostine in reducing cisplatin toxicity.

1 reference

12 December 2020

Retrospective review of chemotherapy for small cell lung cancer in the elderly: does the end justify the means?

1 reference

12 December 2020

Small cell lung cancer in the elderly

1 reference

12 December 2020

Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer

1 reference

12 December 2020

Prognostic factors in small cell carcinoma of the lung: a cancer and leukemia group B study

1 reference

12 December 2020

An analysis of the outcomes of treatment of small cell lung cancer in the elderly

1 reference

12 December 2020

Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients

1 reference

12 December 2020

Adriamycin, cyclophosphamide, and etoposide (VP-16–213) in extensive-stage small cell lung cancer

1 reference

12 December 2020

Treatment of small cell lung carcinoma in the elderly

1 reference

12 December 2020

Second-line carboplatin-based chemotherapy for small cell lung cancer: the Groningen experience

1 reference

12 December 2020

Abbreviated treatment for elderly, infirm, or noncompliant patients with limited-stage small-cell lung cancer

1 reference

12 December 2020

Age as a risk factor for inadequate treatment

1 reference

12 December 2020

Pretreatment prognostic factors for survival in small-cell lung cancer: a new prognostic index and validation of three known prognostic indices on 341 patients

1 reference

12 December 2020

Carboplatin-containing regimens for small cell lung cancer: implications for management in the elderly

1 reference

12 December 2020

The current role and future prospects of paclitaxel in the treatment of small cell lung cancer

1 reference

12 December 2020

Prognostic factors in small cell lung cancer: a simple prognostic index is better than conventional staging

1 reference

12 December 2020

Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study

1 reference

12 December 2020

Carboplatin, etoposide, and accelerated hyperfractionated radiotherapy for elderly patients with limited small cell lung carcinoma: a phase II study

1 reference

12 December 2020

Predicting septic complications of chemotherapy: an analysis of 382 patients treated for small cell lung cancer without dose reduction after major sepsis

1 reference

12 December 2020

Lung cancer in the elderly

1 reference

12 December 2020

The efficacy of IL-3, SCF, IL-6, and IL-11 in treating thrombocytopenia

1 reference

12 December 2020

A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Canc

1 reference

12 December 2020

Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung Cancer

1 reference

12 December 2020

Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist

1 reference

12 December 2020

1 reference

12 December 2020

A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer

1 reference

12 December 2020

The Consensus Conference on Comprehensive Geriatric Assessment: A Dialogue is the Beginning of Consensus

1 reference

12 December 2020

Phase II study of carboplatin and adriamycin as second line chemotherapy in small cell lung cancer

1 reference

12 December 2020

Second-line chemotherapy in small cell lung cancer

1 reference

12 December 2020

Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer

1 reference

12 December 2020

An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research

1 reference

12 December 2020

Clinical status and optimal use of amifostine

1 reference

12 December 2020

Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group

1 reference

12 December 2020

The clinical impact of teniposide in the treatment of elderly patients with small-cell lung cancer.

1 reference

12 December 2020

Neurological and cognitive impairment in long-term survivors of small cell lung cancer

1 reference

12 December 2020

Incidence of neutropenic fever in patients treated with standard-dose combination chemotherapy for small-cell lung cancer and the cost impact of treatment with granulocyte colony-stimulating factor

1 reference

12 December 2020

Cancer chemotherapy in the elderly.

1 reference

12 December 2020

Epirubicin in previously untreated patients with small cell lung cancer: a phase II study by the EORTC Lung Cancer Cooperative Group

1 reference

12 December 2020

Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer.

1 reference

12 December 2020

Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group

1 reference

12 December 2020

Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party

1 reference

12 December 2020

Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews

1 reference

12 December 2020

Lung carcinoma in the elderly population. Influence of histology on the inverse relationship of stage to age

1 reference

12 December 2020

Treatment of oat cell carcinoma of the lung: complete remissions, acceptable complications, and improved survival

1 reference

12 December 2020

Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer

1 reference

12 December 2020

A phase II study of oral etoposide in elderly patients with small cell lung cancer

1 reference

12 December 2020

Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group

1 reference

12 December 2020

Patients at risk of chemotherapy-associated toxicity in small cell lung cancer

1 reference

12 December 2020

Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest

1 reference

12 December 2020

Pharmacology of antineoplastic agents in the elderly patient

1 reference

12 December 2020

Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): The role of sex as a predictor for survival

1 reference

12 December 2020

Validation of a multidimensional evaluation scale for use in elderly cancer patients

1 reference

12 December 2020

Renal toxicities of chemotherapy

1 reference

12 December 2020

Defining and analysing symptom palliation in cancer clinical trials: a deceptively difficult exercise

1 reference

12 December 2020

Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy

1 reference

12 December 2020

Gastrointestinal toxicity of chemotherapeutic agents.

1 reference

12 December 2020

Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and

1 reference

12 December 2020

The aged patient with lung cancer. Management recommendations.

1 reference

12 December 2020

10.2165/00002512-200017030-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1034757228

0 references

1 reference